核医学在中国的风景,以及其在超神学方面的进展
Weidong Yang1, Fei Kang1, Yue Chen2
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
概括
中国的核医学取得了显著的进步,放射性药物行业不断增长,新的诊断标记物也在不断发展. 预计未来的增长,目标是到2035年在全国范围内扩大服务.
科学领域:
- 核医学是一种核医学.
- 放射性药物制药行业 放射性药物制药行业
- 精准医学是一门精准的医学.
背景情况:
- 中国的核医学始于1956年,由于经济增长和精准医学的进步,已经取得了重大进展.
- 目前,它涉及大约13,000名专业人员,每年在近1200家医院为超过390万名患者提供服务.
- 过去十年,放射性药物行业发展迅速,为临床和研究应用建立了全面的产业链.
研究的目的:
- 突出中国核医学近期的进展和未来的潜力.
- 讨论放射性药物生产,设备制造和新型标记物的临床转化方面的进展.
- 概述未来10-20年中国核医学服务的预期增长和扩张.
主要方法:
- 审查中国核医学行业的现状和最近的发展.
- 分析放射性制药行业的基础设施和制造能力.
- 检查研究趋势,包括新的追踪器开发和theranostics.
- 考虑政府倡议和医疗同位素的未来发展计划.
主要成果:
- 核医学取得了显著的进步,其证据包括强大的放射性药物工业和国内制造PET/CT扫描仪等先进设备.
- 针对性探针的临床应用越来越多,包括用-68 (68Ga) 和-177 (177Lu) 标记的药物用于theranostics.
- 预计到2035年,核医学规模将翻一番,并扩大覆盖范围,覆盖所有高级医院和全国"一个县,一个部门"目标.
结论:
- 中国的核医学有望大幅增长,这是由创新和支持性政府政策推动的,例如医疗同位素中长期发展计划 (2021-2035年).
- 制造业的独立创新有望缓解放射性药物短缺问题.
- 该领域正在向更广泛地实施先进的诊断和治疗核医学技术迈进.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
111
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
111
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Radiological Investigation III: Pulmonary Angiogram and PET Scan
91
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
91
Radiological Investigation I: X-ray and CT
232
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
232


